Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-016700

President and CEO sold 3,506 shares at $3.16 ($11,079)

From the SEC's structured data for this filing

Trades in this filing

Paulson Richard A. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-03-06 Sale : show line 1 in the form −3,506 $3.16 $11,079 820,116 D
Open-market sales · 3,506 sh · avg $3.16 · $11,079
Loading xslF345X03/doc4.xml…